FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/27/2023
Back to search
Official data from USPTO
GM GENEMEDICINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
02/27/2023
Trademark type
Combined
Nice classes
5, 42
Filing date
05/17/2021
Registration date
10/18/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/18/2022
Last transaction
10/18/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
KR
Examiner
SOTLAND, THEODORE
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized letters "GM" inside a circle above the stylized wording "GENEMEDICINE".
Holders and representatives
Holders
GeneMedicine Co., Ltd.
Representatives
Jae Youn Kim Novick, Kim & Lee, PLLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Milk sugar for medical purposes; sanitizing preparations for household use; pharmaceutical agents affecting sensory organs; pharmaceutical products for the treatment of viral diseases; vaccines; vitamin preparations; fungicides; antiseptic washing preparations; pharmaceutical products for the treatment of cancer; diagnostic agents for pharmaceutical use; clinical medical reagents; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparationsantivirals; anti-cancer preparations; dietary supplements for medical use; biological tissue cultures for medical purposes; implants comprising living tissue; antiseptic cotton; dental adhesives; food for babies
Class 42
Drug discovery services; research on the subject of pharmaceuticals; bacteriological research and analysis; bacteriological research; scientific research for medical purposes in the area of cancerous diseases; medical research services; engineering design services; computer programming in the medical field; structural and functional analysis of genomes; biotechnology research; biomedical research services; biochemical research and analysis; chemical research services; DNA screening for scientific research purposes; genetic testing for scientific research purposes
Publications
History of USPTO decisions and trademark events.
31 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/03/2023
FIMP
FINAL DISPOSITION PROCESSED
02/03/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/18/2023
GPNX
NOTIFICATION PROCESSED BY IB
12/28/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/18/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
10/18/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/02/2022
PUBO
PUBLISHED FOR OPPOSITION
08/02/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/13/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/13/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/13/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/24/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/24/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/24/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/24/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/03/2022
GNRT
NON-FINAL ACTION E-MAILED
05/03/2022
CNRT
NON-FINAL ACTION WRITTEN
05/03/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/23/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/23/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/23/2022
RFNT
REFUSAL PROCESSED BY IB
03/21/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/02/2022
RFRR
REFUSAL PROCESSED BY MPU
03/02/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/03/2022
CNRT
NON-FINAL ACTION WRITTEN
02/02/2022
DOCK
ASSIGNED TO EXAMINER
01/26/2022
MAFR
APPLICATION FILING RECEIPT MAILED
07/01/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/27/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/24/2021
Continuous trademark protection
Get notified about every new filing that threatens GM GENEMEDICINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.